These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 6789438

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Present aspects of the treatment of hemochromatosis (apropos of 100 observations)].
    Darnis F, Mossé A, Breauté C, Delorme ML.
    Ann Med Interne (Paris); 1971 Dec; 122(12):1193-210. PubMed ID: 5151624
    [No Abstract] [Full Text] [Related]

  • 23. [Iron storage disease].
    Heilmeyer L.
    Munch Med Wochenschr; 1967 Mar 31; 109(13):677-84. PubMed ID: 5631729
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of iron overload.
    Cohen A, Witzleben C, Schwartz E.
    Semin Liver Dis; 1984 Aug 31; 4(3):228-38. PubMed ID: 6091277
    [No Abstract] [Full Text] [Related]

  • 25. Chelation in metal intoxication. XIII. Polyaminocarboxylic acids as chelators in lead poisoning.
    Tandon SK, Behari JR, Singh S.
    Bull Environ Contam Toxicol; 1983 May 31; 30(5):552-8. PubMed ID: 6407551
    [No Abstract] [Full Text] [Related]

  • 26. Iron overload: pathogenesis and treatment with chelating agents.
    Huebers H.
    Blut; 1983 Aug 31; 47(2):61-7. PubMed ID: 6871476
    [No Abstract] [Full Text] [Related]

  • 27. Chelation therapy for the treatment of thalassemia.
    Graziano JH, Cerami A.
    Semin Hematol; 1977 Jan 31; 14(1):127-34. PubMed ID: 318766
    [No Abstract] [Full Text] [Related]

  • 28. Thalassemia.
    Brown EB.
    Prog Clin Biol Res; 1983 Jan 31; 127():33-42. PubMed ID: 6889403
    [No Abstract] [Full Text] [Related]

  • 29. Investigations into techniques for removing intracellular plutonium--II. Complexing agents bound to macromolecules.
    Bulman RA, Griffin RJ.
    Health Phys; 1981 Feb 31; 40(2):228-31. PubMed ID: 6163749
    [No Abstract] [Full Text] [Related]

  • 30. Desferal therapy in iron storage disease.
    Thompson RB, Owen DM, Bell WN.
    Am J Med Sci; 1967 Apr 31; 253(4):453-60. PubMed ID: 6021380
    [No Abstract] [Full Text] [Related]

  • 31. Iron toxicity treated with deferoxamine.
    Greenberg MS, Rosen B, Keating J.
    Clin Pediatr (Phila); 1966 Aug 31; 5(8):485-92. PubMed ID: 4957883
    [No Abstract] [Full Text] [Related]

  • 32. [Idiopathic hemochromatosis].
    Mikuz G, Goldberg K, Propst A.
    Med Welt; 1971 Mar 06; 10():363-7. PubMed ID: 5549133
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Therapeutic chelating agents.
    Jones MM, Pratt TH.
    J Chem Educ; 1976 Jun 06; 53(6):342-7. PubMed ID: 818097
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [DESFERRIOXAMINE (DF) AND DIETHYLENE TRIAMINE PENTA-ACETIC ACID TRISODIUM CALCIUM SALT (CA DTPA NA3) IN SIDEROSIS. 2].
    ALBAHARY C.
    Presse Med (1893); 1965 Jan 09; 73():73-6. PubMed ID: 14234334
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Decreased effectiveness of chelation therapy with time after acute cadmium poisoning.
    Cantilena LR, Klaassen CD.
    Toxicol Appl Pharmacol; 1982 Apr 09; 63(2):173-80. PubMed ID: 6283691
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.